Clinical Trials Directory

Trials / Completed

CompletedNCT00713167

The Efficacy of Red Grape Seed Extract on Lipid Profile and Oxidized Low-Density Lipoprotein (OX-LDL)

Randomized, Cross-Over, Double Blind, Placebo-Controlled Study of Grape Seed Extract in Treating Patients With Mild Hyperlipidemia

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
55 (actual)
Sponsor
Shahid Beheshti University of Medical Sciences · Academic / Other
Sex
All
Age
21 Years – 64 Years
Healthy volunteers
Not accepted

Summary

Antioxidants are potent scavengers of free radicals and serve as inhibitors of neoplastic processes. A large number of synthetic and natural antioxidants are known to induce beneficial effects on human health and disease prevention. Cardioprotective ability of grape seed extract polyphenols (GSEP) was studied in animals and humans. It has been suggested that grape seed proanthocyanidins have cardioprotective effects against reperfusion-induced injury of free radicals after ischemia. In another study, it is suggested that proanthocyanidins, the major polyphenols in red wine, might trap reactive oxygen species in aqueous series such as plasma and interstitial fluid of the arterial wall; thereby inhibiting oxidation of low-density lipoprotein (LDL) and showing an antiatherosclerotic activity. The only human model study designed to evaluate the effect of a standardized formulation of a GSEP (leucoselect-phytosome \[LP\]) on the susceptibility of LDL to oxidation in a group of heavy smokers, revealed that the antioxidant potential of GSEP may be effective in oxidative stress (smoking); however more investigational data are needed before wider use in clinical settings. Based on these observations, the investigators decided to evaluate the effect of GSEP in reducing OX-LDL in patients diagnosed with mild hyperlipidemia.

Conditions

Interventions

TypeNameDescription
DRUGGrape Seed Extract (Vitagrape)Drug {Each Containing: Grape Seed Extract100 mg +...} 1 capsule twice daily for 2 months
DRUGPlacebo of Grape Seed ExtractPlacebo {Each Containing: Gelatin 17mg + Cellulose Microcrystalline (Avicel) 67 mg + Dicalcium Phosphate 216mg} 1 capsule twice daily for 2 months

Timeline

Start date
2008-07-01
Primary completion
2008-12-01
Completion
2009-02-01
First posted
2008-07-11
Last updated
2009-05-21

Locations

2 sites across 1 country: Iran

Source: ClinicalTrials.gov record NCT00713167. Inclusion in this directory is not an endorsement.